141 related articles for article (PubMed ID: 3847272)
1. In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species.
Varaldo PE; Debbia E; Schito GC
Antimicrob Agents Chemother; 1985 Apr; 27(4):615-8. PubMed ID: 3847272
[TBL] [Abstract][Full Text] [Related]
2. In-vitro effects of vancomycin and rifampicin, alone and in combination, against methicillin-sensitive and methicillin-resistant staphylococci.
Varaldo PE; Debbia E; Schito GC
J Antimicrob Chemother; 1984 Dec; 14 Suppl D():35-41. PubMed ID: 6569872
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis.
Ein ME; Smith NJ; Aruffo JF; Heerema MS; Bradshaw MW; Williams TW
Antimicrob Agents Chemother; 1979 Nov; 16(5):655-9. PubMed ID: 260880
[TBL] [Abstract][Full Text] [Related]
4. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
Lowy FD; Chang DS; Lash PR
Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
[TBL] [Abstract][Full Text] [Related]
5. Interaction between rifampin and fusidic acid against methicillin-resistant coagulase-positive and -negative staphylococci.
Farber BF; Yee YC; Karchmer AW
Antimicrob Agents Chemother; 1986 Jul; 30(1):174-5. PubMed ID: 3638931
[TBL] [Abstract][Full Text] [Related]
6. Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy.
Varaldo PE; Cipriani P; Focá A; Geraci C; Giordano A; Madeddu MA; Orsi A; Pompei R; Prenna M; Repetto A
J Clin Microbiol; 1984 Jun; 19(6):838-43. PubMed ID: 6565709
[TBL] [Abstract][Full Text] [Related]
7. New trends in the chemotherapy of staphylococcal infections.
Russo G; Tempera G; Stefani S; Nicoletti G
Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
[TBL] [Abstract][Full Text] [Related]
8. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
Bayer AS; Morrison JO
Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
[TBL] [Abstract][Full Text] [Related]
9. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
[TBL] [Abstract][Full Text] [Related]
10. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
Lowy FD; Wexler MA; Steigbigel NH
J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
[TBL] [Abstract][Full Text] [Related]
11. Antistaphylococcal activity of rifampin with other antibiotics.
Zinner SH; Lagast H; Klastersky J
J Infect Dis; 1981 Oct; 144(4):365-71. PubMed ID: 6270215
[TBL] [Abstract][Full Text] [Related]
12. In vitro interaction between rifampin and clindamycin against pathogenic coagulase-negative staphylococci.
Arditi M; Yogev R
Antimicrob Agents Chemother; 1989 Feb; 33(2):245-7. PubMed ID: 2719468
[TBL] [Abstract][Full Text] [Related]
13. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC
J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267
[TBL] [Abstract][Full Text] [Related]
14. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664
[TBL] [Abstract][Full Text] [Related]
15. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
Chokkavelu V; Chandrasekar P; Rolston K; LeFrock JL; Schell RF
Chemotherapy; 1984; 30(2):97-101. PubMed ID: 6559665
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species.
Rohner P; Herter C; Auckenthaler R; Pechère JC; Waldvogel FA; Lew DP
Antimicrob Agents Chemother; 1989 Dec; 33(12):2037-41. PubMed ID: 2619272
[TBL] [Abstract][Full Text] [Related]
17. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
Watanakunakorn C
Ann Intern Med; 1982 Sep; 97(3):376-8. PubMed ID: 7114635
[TBL] [Abstract][Full Text] [Related]
18. Gentamicin- and methicillin-resistant Staphylococcus aureus: in vitro susceptibility to antimicrobial drugs.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1987; 33(5):361-75. PubMed ID: 3665635
[TBL] [Abstract][Full Text] [Related]
19. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci.
Sachdeva M; Hackbarth C; Stella FB; Chambers HF
Antimicrob Agents Chemother; 1987 Oct; 31(10):1549-52. PubMed ID: 3481245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
